Conatus Pharmaceuticals Inc. buy melinda
Start price
06.12.17
/
50%
€35.45
Target price
08.12.17
€36.98
Performance (%)
4.83%
End price
08.12.17
€37.16
Summary
This prediction ended on 08.12.17 with a price of €37.16. With a performance of 4.83%, the BUY prediction by melinda for Conatus Pharmaceuticals Inc. closed with a slight gain. melinda has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Conatus Pharmaceuticals Inc. | - | - | - | - |
| iShares Core DAX® | 2.489% | -5.941% | 2.896% | 45.717% |
| iShares Nasdaq 100 | 1.649% | -2.462% | 15.754% | 73.262% |
| iShares Nikkei 225® | 0.555% | -7.597% | 30.353% | 48.769% |
| iShares S&P 500 | 1.347% | -2.943% | 10.338% | 55.803% |
Comments by melinda for this prediction
In the thread Conatus Pharmaceuticals Inc. diskutieren
Biotechnologie und medizinische SecteurRecherche
A +
Stopped prediction by melinda for Conatus Pharmaceuticals Inc.
Conatus Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€10.46
02.04.19
02.04.19
€19.84
30.10.19
30.10.19
-79.93%
30.10.19
30.10.19
Conatus Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€14.61
11.12.18
11.12.18
€27.06
09.01.19
09.01.19
29.63%
09.01.19
09.01.19
Conatus Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€43.48
06.02.17
06.02.17
€49.61
30.03.17
30.03.17
5.62%
30.03.17
30.03.17